Chatterjee et al, Idiotypic antibody immunotherapy of cancer, Cancer Immuno. Immunother. 38: 75-82. Jan. 1994.* |
Osband et al, Problems in the investigational study and clinical use of cancer immuotherapy, Immunology Today 11(6): 193-195. Jun. 1990.* |
Lemoli et al, Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells, Br. J. Haematology 88(4): 760-769. Apr. 13, 1994.* |
Heidari et al, Characterization of the Growth Factor Activity of Amniotic Fluid on Cells from Hematopoietic and Lymphoid Organs of Different Life Stages, Microbiol. Immunol. 40(8):583-589. Aug. 23, 1996.* |
Harlow et al, Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, pp. 71-82. Dec. 1988.* |
Dunham et al DNA Sequence vol. 6 233-237, 1996.* |
Efferth et al Med Oncol Tumor Pharmacology vol. 9(1) 11-19, 1992.* |
Blair et al J Bone Mineral Res vol. 12 Suppl 1 T380 p. S196, Aug. 1997.* |
Seaver Genetic Engineering vol. 14 No. 14 pp. 10 and 21 Aug. 1994.* |
Battei et al J Cellular Biochem Suppl vol. 0 No. 18 Part A p. 23 Abstract 300, 1994.* |
a. Eric J. Huang, et al. Differential Expression and Processing of Two Cell Associated Forms of the Kit-Ligand: KL-1 and KL-2, Molecular Biology of the Cell, vol. 3, pp. 349-362 (Mar. 1992). |
b. Manas K. Majumdar, et al. Identification and Mutation of Primary and Secondary Proteolytic Cleavage Sites in Murine Stem Cell Factor cDNA Yields Biologically Active, Cell-associated Protein, The Journal of Biological Chemistry, vol. 269, No. 2, pp. 1237-1242 (Jan. 14, 1994). |
c. Wayne E. Taylor, et al. Human Stem Cell Factor Promoter Deoxyribonucleic Acid Sequence and Regulation by Cyclic 3′, 5′-Adenosine Monophosphate in a Sertoli Cell Line, Endocrinology, vol. 137, No. 12, pp. 5407-5414 (1996). |
d. Krisztina M. Zsebo, et al. Stem Cell Factor Is Encoded at the SI Locus of the Mouse and Is the Ligand for the c-kit Tyrosine Kinase Receptor, Cell, vol. 63, pp. 213-224 (Oct. 5, 1990). |
e. Dirk M. Anderson, et al. Molecular Cloning of Mast Cell Growth Factor, a Hematopoietin that Is Active in Both Membrane Bound and Soluble Forms, Cell, vol. 63, pp. 235-243 (Oct. 5, 1990). |
f. Eric Huang, et al. The Hematopoietic Growth Factor KL is Encoded by the SI Locus and Is the Ligand of the c-kit Receptor, the Gene Product of the W Locus, Cell, vol., 63 pp. 225-233 (Oct. 5, 1990). |
g. Francis H. Martin, et al. Primary Structure and Functional Expression of Rat and Human Stem Cell Factor KNAs, Cell, vol. 63, pp. 203-211 (Oct. 5, 1990). |
h. Feihua Qiu, et al. Primary Structure of c-kit: Relationship with the CSF-1/PDGF Receptor Kinase Family-Oncogenic Activation of v-kit Involves Deletion of Extracellular Domain and C Terminus, The EMBO Journal, vol. 7, No. 4, pp. 1003-1011 (1988). |
i. R.J. Van't Hof, et al. Stem Cell Factor Stimulates Chicken Osteoclast Activity in vitro, FASEB Journal, vol. 11, pp. 287-293 (1997). |
j. Valter Gattei, et al. Human Osteoclasts and Preosteoclast Cells (FLG 29.1) Express Functional c-kit Receptors and Interact with Osteoblast and Stromal Cells via Membrane-bound Stem Cell Factor, Cell Growth and Differentiation, vol. 7, pp. 753-763 (Jun. 1996). |
k. L. Pierelli, et al. Generation of Multinuclear Tartrate-resistant Acid Phosphatase Positive Osteoclasts in Liquid Culture of Purified Human Peripheral Blood CD34 +Progenitors, British Journal of Haematology, vol. 96, No. 1, pp. 64-69 (Jan. 1997). |
l. Y. Hayase, et al. Osteoclast Development from Hematopoietic Stem Cells: Apparent Divergence of the Osteoclast Lineage Prior to macrophage Commitment, Experimental Hematology, vol. 25, No. 1, pp. 10-25 (Jan. 1997). |
m. S. Roux, et al. Human Cord Blood Monocytes Undergo Terminal Osteoclast Differentiation in vitro in the Presence of Culture Medium Conditioned by Giant Cell tumor of Bone, Journal of Cellular Phusiology, vol. 168, No. 3, pp. 489-498 (Sep. 1996). |
n. S. Takahashi, et al. Development and Characterization of a Human Marrow Stromal Cell Line that Enhances Osteoclast-Like Cell-Like Formation, Endocrinology, vol. 136, No. 4, pp. 1441-1449 (Apr. 1995). |